Myomo (MYO) announces the launch of the Myomo Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro experience. “For clinicians, the Myomo Mobile App is designed to simplify device configuration and improve visibility into patient use, whether care is delivered in clinic or remotely,” said Paul R. Gudonis, Myomo’s Chairman and Chief Executive Officer. “For patients, the app helps make muscle activity more understandable and encourages confidence through real-time feedback and easy access to training resources.” The Myomo Mobile App is now available through the Google Play Store and Apple App Store and supporting user manuals for clinicians, patients, and caregivers are available on the company’s website.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYO:
- Myomo Adds Will Febbo to Board for Growth
- Myomo price target lowered to $3 from $4 at Alliance Global
- Myomo Inc. Flags High Risk in Forward-Looking Statements, Urges Caution on Reimbursement, Financing and Growth Plans
- Myomo: Buy Rating Reaffirmed on Channel Shift, Margin Expansion, and Path to Breakeven by 2027
- Closing Bell Movers: Casey’s slips 2%, HP Enterprise up marginally